Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-26

FDA Approved: LEVALBUTEROL — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's LEVALBUTEROL as a generic inhalation solution (Original Application) for preventing and treating bronchospasm in reversible airway diseases …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levalbuterol (Levalbuterol)

Snippet

ORIG AP for LEVALBUTEROL (LEVALBUTEROL)